The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine

BACKGROUND: Sigma-2 receptors are over-expressed in proliferating cancer cells, making an attractive target for the targeted treatment of pancreatic cancer. In this study, we investigated the role of the novel sigma-2 receptor ligand SW43 to induce apoptosis and augment standard chemotherapy. RESULT...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hornick, John R, Xu, Jinbin, Vangveravong, Suwanna, Tu, Zhude, Mitchem, Jonathan B, Spitzer, Dirk, Goedegebuure, Peter, Mach, Robert H, Hawkins, William G
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2010
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3106998/
https://ncbi.nlm.nih.gov/pubmed/21092190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-298
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak